If your blood type is A, your genotype is either AA (two copies of the A allele) or AO (one A allele and one O allele). That two-option answer is what most biology classes teach, and it is correct as far as it goes. But when you zoom in, the picture gets more interesting. The A allele itself comes in more than one version, the O allele has variants too, and rare genetic quirks can make someone with A-type genes test as something else entirely.
The Two Core Genotypes
Blood type is determined by a single gene on chromosome 9. That gene codes for an enzyme that attaches a specific sugar to a molecule called the H antigen on the surface of your red blood cells. The A version of the gene produces an enzyme that adds N-acetylgalactosamine to the H antigen, creating the A antigen. The B version adds a different sugar, galactose. The O version produces no functional enzyme at all, leaving the H antigen unmodified.1Nature Structural Biology. The structural basis for specificity in human ABO(H) blood group biosynthesis
Because you inherit one allele from each parent, having type A blood means you received at least one working A allele. The second allele can be either another A or an O. An O allele is functionally silent, so AO produces the same surface antigen as AA. Standard blood bank tests cannot distinguish between the two. If you are type A and want to know which genotype you carry, genetic testing is the only definitive method.
Why does the distinction matter? Mostly for predicting what blood types your children could have. If you are AA, every child inherits an A allele from you. If you are AO, each child has a roughly equal chance of getting your A or your O. A couple where both parents are AO can have a child with type O blood, which sometimes catches families off guard.
A1 and A2 Subtypes Multiply the Options
The “A allele” is not a single thing. Most people with type A blood carry the A1 variant, but roughly one in five carry the A2 variant instead. These two versions produce enzymes that differ in how efficiently they work. The A1 enzyme has a strong affinity for both its donor sugar and its acceptor molecule, while the A2 enzyme has markedly lower affinity for both.2PubMed Central. An enzyme basis for blood type A intermediate status The practical result is that A1 red blood cells are coated with far more A antigen than A2 cells. Laboratory research confirmed decades ago that the A1 and A2 enzymes differ not just in quantity but in their biochemical properties, including their pH optima and ion requirements.3PubMed Central. Qualitative differences in the N-acetyl-D-galactosaminyltransferases produced by human A1 and A2 genes
Factor in two common O allele variants (O1 and O2) alongside A1 and A2, and the real list of type-A genotypes expands well beyond two. A genotyping study of a Kuwaiti population that used restriction-enzyme digestion to distinguish allele variants identified multiple type-A genotypes at specific frequencies: A1A1 at about 0.3%, A1A2 at roughly 1.7%, A1O1 at about 11%, A1O2 at 0.3%, A2A2 at 0.3%, and A2O1 at about 8.5%.4PubMed. Molecular genotyping and frequencies of A1, A2, B, O1 and O2 alleles of the ABO blood group system in a Kuwaiti population These proportions shift across populations, but the principle holds everywhere: the simple “AA or AO” answer is a shorthand for at least six distinct genotype combinations when the major subtypes are counted.
Why Your Blood Bank Card Does Not Tell You Your Genotype
Routine blood typing relies on serology: a technician mixes your red blood cells with anti-A and anti-B antibodies and watches for clumping. If your cells clump with anti-A but not anti-B, you are type A. This test tells you what antigen is on your cells, not what genes produced it. An AA person and an AO person look identical under this method, and in most clinical settings, the distinction is irrelevant for safe transfusion.
DNA-based genotyping goes further. High-throughput platforms can now read the actual nucleotide sequence of the ABO gene and identify not just A versus O but A1 versus A2, O1 versus O2, and many rare variants. These systems provide much more comprehensive information about a person’s blood group than serology alone and are easier to standardize across laboratories.5PubMed. Large-scale blood group genotyping: clinical implications Genomic analysis of common and rare ABO alleles has shown that sequence variations within the full coding region can affect A- and B-antigen expression, meaning even subtle changes in the gene’s DNA can shift how much antigen ends up on your cells.6Blood. The nature of diversity and diversification at the ABO locus
For most people, genetic typing is unnecessary. It becomes relevant in complex transfusion situations, organ transplant matching, paternity testing, forensic identification, and cases where serological results are ambiguous.
Weak A Subgroups and Beyond
A1 and A2 are the common subtypes, but the ABO gene is remarkably variable. Dozens of rare “weak A” alleles have been catalogued, producing subtypes like A3, Ax, Aend, Ael, and others. These variants generate so little A antigen that they can be missed on standard typing or misidentified as type O. Molecular investigation of the A3 phenotype revealed that some A3 alleles carry a single-base substitution that changes one amino acid in the enzyme, while other A3 alleles have no detectable coding-region mutations at all, demonstrating heterogeneity even within a single subgroup.7PubMed. Molecular genetic analysis of the ABO blood group system: 1. Weak subgroups: A3 and B3 alleles
A large-scale screening in China found 351 individuals with weak ABO subgroups among 1.45 million blood-typed subjects, and the researchers identified ten novel weak-subgroup alleles in that sample alone.8PubMed Central. Molecular genetic analysis of weak ABO subgroups in the Chinese population reveals ten novel ABO subgroup alleles That frequency is low in absolute terms, but across billions of people worldwide, weak A subgroups are far from negligible. If you carry one, your serological type might read as “A-weak” or be flagged for further investigation, and your genotype would be written as something like A3O1 or AxO2 rather than the textbook AA or AO.
When A Genotype Does Not Produce A Blood Type
There is a scenario where someone can carry a perfectly normal A allele and still type as O on a blood test. The Bombay and para-Bombay phenotypes involve a separate gene altogether, the FUT1 gene (also called the H gene), which builds the H antigen that the ABO enzymes work on. If you lack a functioning FUT1 gene, you produce little or no H antigen. Without H antigen as a foundation, the A enzyme has nothing to modify, and no A antigen appears on your red blood cells. Routine serology will call you type O even though your ABO genotype might be AA or AO.9Journal of Men’s Health. ABO discrepancy due to the para-Bombay phenotype: a case report
The Bombay phenotype is extremely rare in most populations but occurs more frequently in parts of South Asia. It matters enormously for transfusion safety because a person with the Bombay phenotype has antibodies against the H antigen itself, meaning they can only safely receive blood from another Bombay donor. A mistyped Bombay individual given standard type O blood could have a severe reaction. This is one of the strongest arguments for DNA-based genotyping in complex cases.
Cis-AB and Other Genetic Curveballs
Another rare twist involves an allele called cis-AB, in which a single copy of the ABO gene produces both A and B antigens. Normally, A and B come from separate alleles on separate chromosomes. In cis-AB, mutations within one allele shift the enzyme’s specificity so that it adds both sugars, creating a hybrid output from a single gene inherited from one parent.10PubMed Central. Cis-AB, the Blood Group of Many Faces, Is a Conundrum to the Novice Eye A person carrying a cis-AB allele paired with an O allele will type as AB despite having received no B allele from either parent. This defies the normal inheritance rules and can cause confusion in paternity cases or family blood-type predictions.
Case reports of cis-AB have come from populations around the world. One Indian case involved a patient whose blood typed as A2B3 and was subsequently confirmed through molecular analysis to carry a cis-AB allele.11PubMed. Molecular analysis and transfusion management in a rare case of cis-AB blood group: A report from India These cases are uncommon enough that many blood bank technicians will encounter only a handful in an entire career, but they reinforce the point that genotype and phenotype in the ABO system do not always line up neatly.
When Type A Picks Up a False B Antigen
Disease states can temporarily alter what appears on your red blood cells. The “acquired B” phenomenon occurs exclusively in people with type A blood. In certain bacterial infections, particularly of the gastrointestinal tract, enzymes produced by bacteria can modify the A antigen so that it cross-reacts with anti-B reagents. The person’s blood suddenly appears to type as AB, even though their genotype has not changed.12Korean Journal of Hematology. Two Cases of ABO Typing Discrepancy by Acquired B Antigen
This can have dangerous consequences. One documented case involved a fatal hemolytic transfusion reaction that occurred because the patient’s acquired B antigen was detected by some monoclonal anti-B reagents, leading to an incorrect AB typing and a transfusion of incompatible blood.13PubMed. Fatal hemolytic transfusion reaction resulting from ABO mistyping of a patient with acquired B antigen detectable only by some monoclonal anti-B reagents The condition resolves when the underlying infection is treated, and the person’s blood reverts to its true type A. Blood bank staff are trained to suspect acquired B when a patient who has always typed as A suddenly appears to be AB, especially in the context of gastrointestinal illness.
Practical Implications of the A1 versus A2 Distinction
For everyday transfusion, A1 and A2 individuals are treated the same. Both receive type A or type O red blood cells without issue in the vast majority of cases. The wrinkle comes with antibodies. About one to two percent of A2 individuals develop anti-A1 antibodies, cold-reacting antibodies that recognize the extra A antigen on A1 cells. The rate is higher among A2B individuals, where roughly a quarter to a third produce anti-A1.14PubMed Central. Transfusion in Blood Group A2B with Anti A1 Recipient These antibodies are usually harmless because they only react at cool temperatures, well below body temperature. Occasionally, though, they are active at body temperature and can cause cross-matching difficulties or transfusion reactions. When that happens, the patient needs A2 or O donor blood specifically.
Health Risks Linked to Type A Genotype
Beyond transfusion, your ABO genotype has been linked to susceptibility to several diseases, though the effect sizes are generally modest. In the area of cardiovascular risk, plasma levels of von Willebrand factor and factor VIII, both involved in blood clotting, are positively associated with the number of A1 or B alleles a person carries.15PubMed Central. ABO Genotype and Risk of Thrombotic Events and Hemorrhagic Stroke This means an AA individual, carrying two copies of the A allele, tends to have higher clotting factor levels than an AO individual with just one. The result is a graded increase in thrombotic risk that tracks with the number of non-O alleles, not just the blood type label on your card.
Cancer research has turned up associations as well. A study of esophageal and gastric cancers found that type A individuals had a statistically elevated risk of gastric noncardia adenocarcinoma compared to type O, with a risk ratio of about 1.37.16PubMed Central. ABO genotypes and the risk of esophageal and gastric cancers Separate work specifically examining genotype rather than serological type found that gastric cancer risk increased with the addition of each A allele, while each B allele was associated with lower risk. Compared to the AA genotype, OO individuals had about 30% lower gastric cancer risk, and BO carriers had roughly half the risk.17Cancer Epidemiology, Biomarkers & Prevention. ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection These are population-level associations, not individual diagnoses. Carrying an A allele does not mean you will develop gastric cancer any more than not carrying one means you are safe. But it is a reminder that the distinction between AA and AO is not purely academic.
Type A and Infectious Disease
The ABO antigens on your red blood cells are not just bystanders. They interact directly with pathogens. In the case of malaria, the A antigen on red blood cells helps the parasite Plasmodium falciparum form rosettes, clumps of infected and uninfected red blood cells that obstruct small blood vessels. The parasite’s surface protein PfEMP1 specifically recognizes the A-trisaccharide motif, stabilizing these rosettes. Type O red blood cells, which lack A and B antigens, form rosettes at dramatically lower rates.18Frontiers in Cellular and Infection Microbiology. Blood group antigens and malaria susceptibility
Genotype matters here too, not just phenotype. Individuals who are homozygous for non-O alleles (AA, BB, or AB genotype) show higher risk of severe malaria than those who are heterozygous (AO or BO), suggesting a gene-dosage effect: two copies of an antigen-producing allele mean more antigen on each cell, which means more rosetting. A hospital-based study in northeast Ethiopia found that individuals with type A blood had over twice the odds of malaria infection compared to those with type O.19PubMed Central. Prevalence and Association of Malaria With the Blood Group on Febrile Patients at Woldia Comprehensive Specialized Hospital, Northeast Ethiopia This selective pressure from malaria is one reason the O allele remains so common in populations historically exposed to the disease.
Why the A and O Alleles Have Persisted for So Long
The ABO blood group system is ancient. Genetic analysis has shown that the A and B blood groups represent a trans-species polymorphism, meaning the variation predates the split between humans and other primates. The A and B alleles have been maintained under balancing selection for tens of millions of years, making the ABO system one of the oldest known examples of this kind of long-term genetic balancing act outside the immune system’s major histocompatibility complex.20PubMed Central. The ABO blood group is a trans-species polymorphism in primates Phylogenetic reconstruction suggests that B alleles have arisen independently from an ancestral A form at least three times in primate history.21Molecular Biology and Evolution. Evolution of primate ABO blood group genes and their homologous genes
The O allele, by contrast, is a loss-of-function mutation. It keeps arising because it confers advantages against certain diseases, particularly malaria, while the A and B alleles are presumably preserved by advantages in other contexts, possibly related to immune defense against different pathogens. This evolutionary tug-of-war is why no single allele has won out. It also means the AA versus AO question is not just a genetics textbook exercise. It reflects a deep history of competing selective pressures that have kept both alleles circulating in human populations for far longer than our species has existed.
Alpha-Gal and the Immune Quirks of Carrying an A Antigen
There is an intriguing immunological footnote to carrying a type A genotype. All healthy people produce antibodies against a sugar called alpha-gal, which is found on the cells of most mammals other than humans and Old World primates. These anti-alpha-gal antibodies are part of the reason xenotransplantation (using animal organs in humans) remains so difficult. Research has found that the B antigen is structurally similar to the alpha-gal sugar, and individuals with blood type B or AB tend to produce lower levels of anti-alpha-gal antibodies, likely because of partial immune tolerance to the B-like structure.22Experimental & Molecular Medicine. Effect of blood type on anti-α-Gal immunity and the incidence of infectious diseases
Type A individuals, who lack the B antigen, do not have this tolerance issue and generally produce robust anti-alpha-gal antibody levels. This has potential downstream effects. Higher anti-alpha-gal levels may offer some protection against pathogens that carry alpha-gal on their surfaces, including the malaria parasite. The flip side is that these antibodies are also implicated in alpha-gal syndrome, the tick-bite-triggered allergy to red meat. People with type B blood, who make fewer of these antibodies, appear to be underrepresented among alpha-gal syndrome patients. For type A individuals, the full complement of anti-alpha-gal immunity is intact, meaning this particular food allergy pathway is not dampened by blood-type tolerance.